Murdoch University

Diseases, Conditions, Syndromes

Research shows COVID-19 is a multi-organ metabolic disease

Murdoch University's Australian National Phenome Center (ANPC) working with researchers at the University of Cambridge have developed a predictive metabolic model for COVID-19 infection that shows multi-organ effects.

Medical research

New treatment for muscular dystrophy wins US regulatory approval

Research led by Professor Steve Wilton and Professor Sue Fletcher and licensed to Sarepta Therapeutics has delivered a second treatment for Duchenne muscular dystrophy, with the drug gaining accelerated approval by the U.S. ...

page 3 from 9